EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Development of a Method for the In Vivo Generation of Allogeneic Hearts in Chimeric Mouse Embryos

Konstantina-Maria Founta, Magdalini-Ioanna Tourkodimitri, Zoi Kanaki, Sylvia Bisti, Costis Papanayotou

International Journal of Molecular Sciences · 2023

DOI: 10.3390/ijms24021163 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Journal of Molecular Sciences, 2023. Verfasst von Konstantina-Maria Founta und 4 weiteren Autor:innen. Beteiligte Einrichtung: Biomedical Research Foundation Academy of Athens, 115 27 Athina, Greece. Hauptthemen laut MEDLINE: Pluripotent Stem Cells, Hematopoietic Stem Cell Transplantation. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 43 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Hellenic Foundation fo Research and Innovation, Fondation Santé, State Scholarships Foundation.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Worldwide, there is a great gap between the demand and supply of organs for transplantations. Organs generated from the patients’ cells would not only solve the problem of transplant availability but also overcome the complication of incompatibility and tissue rejection by the host immune system. One of the most promising methods tested for the production of organs in vivo is blastocyst complementation (BC). Regrettably, BC is not suitable for the creation of hearts. We have developed a novel method, induced blastocyst complementation (iBC), to surpass this shortcoming. By applying iBC, we generated chimeric mouse embryos, made up of “host” and “donor” cells. We used a specific cardiac enhancer to drive the expression of the diphtheria toxin gene (dtA) in the “host” cells, so that these cells are depleted from the developing hearts, which now consist of “donor” cells. This is a proof-of-concept study, showing that it is possible to produce allogeneic and ultimately, xenogeneic hearts in chimeric organisms. The ultimate goal is to generate, in the future, human hearts in big animals such as pigs, from the patients’ cells, for transplantations. Such a system would generate transplants in a relatively short amount of time, improving the quality of life for countless patients around the world.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Pluripotent Stem CellsHematopoietic Stem Cell TransplantationMiceAnimalsHumansSwineQuality of LifeBlastocystHeart

Stichwörter der Autor:innen

CRISPR-Cas9allogeneic heartin vivo heart generationinduced blastocyst complementationmouse chimerapluripotent stem cells

Autor:innen und Institutionen

  • Biomedical Research Foundation Academy of Athens, 115 27 Athina, Greece.
  • Department of Medicine, University of Patras, 265 04 Patras, Greece.

Förderung

  • Hellenic Foundation fo Research and Innovation
  • Fondation Santé
  • State Scholarships Foundation
  • Greece and the European Union (European Social Fund-ESF)

Zitieren

APA

Founta, K. M., Tourkodimitri, M. I., Kanaki, Z., Bisti, S., & Papanayotou, C. (2023). Development of a Method for the In Vivo Generation of Allogeneic Hearts in Chimeric Mouse Embryos. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms24021163

Vancouver

Founta KM, Tourkodimitri MI, Kanaki Z, Bisti S, Papanayotou C. Development of a Method for the In Vivo Generation of Allogeneic Hearts in Chimeric Mouse Embryos. International Journal of Molecular Sciences. 2023. doi:10.3390/ijms24021163

BibTeX
@article{Founta2023,
  author = {Founta, Konstantina-Maria and Tourkodimitri, Magdalini-Ioanna and Kanaki, Zoi and Bisti, Sylvia and Papanayotou, Costis},
  title = {Development of a Method for the In Vivo Generation of Allogeneic Hearts in Chimeric Mouse Embryos},
  journal = {International Journal of Molecular Sciences},
  year = {2023},
  doi = {10.3390/ijms24021163}
}
Kostenlos starten →